Skip to content

INNOVATION PHARMACEUTICALS INC.

CIK 0001355250

← back to feed
Revenue (TTM)
$0
−100.0% YoY Q1 Sep 2023
Net Income (TTM)
−$3.37M
−5,128.6% YoY Q1 Sep 2023
EPS Diluted (TTM)
−$0.04
−33.3% YoY Q1 Sep 2023
Gross Margin
—
Q1 Sep 2023
Operating Margin
—
Q1 Sep 2023
Net Margin
—
Q1 Sep 2023
Free Cash Flow (TTM)
—
Q1 Sep 2023
Cash
$864K
Q1 Sep 2023
Total Debt
—
Q1 Sep 2023
Shares Outstanding
514.01M sh
Q1 Sep 2023

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings